Abstract 10438: Prevention of Atrial Fibrillation by Bucindolol is Completely Dependent on the Beta-1 389 Arg/Gly Adrenergic Receptor Polymorphism

Ryan G. Aleong,Gordon Davis,William H. Sauer,Alastair D. Robertson,Michael R. Bristow

Abstract 10438: Prevention of Atrial Fibrillation by Bucindolol is Completely Dependent on the Beta-1 389 Arg/Gly Adrenergic Receptor Polymorphism

2011

Ryan G. Aleong
Gordon Davis
William H. Sauer
Alastair D. Robertson
Michael R. Bristow

Beta blockers have modest efficacy for the prevention of atrial fibrillation (AF) in chronic heart failure/reduced ejection fraction (HFREF) populations, with risk reductions on the order of 20-40%...

Keywords:

Atrial fibrillation
Beta-1 adrenergic receptor
Cardiology
Internal medicine
Diabetes mellitus
Adrenergic receptor
Bucindolol
Medicine
Heart failure
Beta (finance)
Ejection fraction
Beta blocker

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations